154 related articles for article (PubMed ID: 18270789)
1. Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma.
Otrock ZK; Hatoum HA; Salem ZM
Intern Emerg Med; 2008 Jun; 3(2):161-3. PubMed ID: 18270789
[No Abstract] [Full Text] [Related]
2. [Acute tumor lysis syndrome (ATLS) during remission induction treatment of Burkitt's lymphoma: study of 26 patients].
Bernacer M; Aracil J; Contra T; Gil C; López J; López-Ibor B; Martín N; Melero C; Valverde F; Vecilla C
An Esp Pediatr; 1988 Oct; 29 Suppl 34():109-12. PubMed ID: 3214014
[No Abstract] [Full Text] [Related]
3. Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma.
Yokohama A; Tsukamoto N; Uchiumi H; Handa H; Matsushima T; Karasawa M; Murakami H; Nojima Y
Ann Hematol; 2004 Feb; 83(2):120-3. PubMed ID: 14513289
[TBL] [Abstract][Full Text] [Related]
4. Conventional dose intensive immunochemotherapy regimen in an adult patient with very late relapse of Burkitt's lymphoma.
Italiano A; Peyrade F; Soler C; Cardot N; Thyss A
J Chemother; 2007 Apr; 19(2):236-8. PubMed ID: 17434838
[No Abstract] [Full Text] [Related]
5. Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.
Jabr FI
Int J Hematol; 2005 Nov; 82(4):312-4. PubMed ID: 16298821
[TBL] [Abstract][Full Text] [Related]
6. Case report: acute tumour lysis syndrome.
Chuah CT; Lim LC
Ann Acad Med Singap; 2001 Jan; 30(1):55-7. PubMed ID: 11242627
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Yang H; Rosove MH; Figlin RA
Am J Hematol; 1999 Dec; 62(4):247-50. PubMed ID: 10589082
[TBL] [Abstract][Full Text] [Related]
8. A case report of fatal tumor lysis syndrome after chemotherapy in a pregnant patient with Burkitt's lymphoma.
Serikawa T; Abe T; Minamikawa T; Itsukaichi M; Yamada K; Saito T; Kaneko T; Wada M; Takakuwa K; Tanaka K
J Obstet Gynaecol Res; 2011 Aug; 37(8):1141-4. PubMed ID: 21481095
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Burkitt lymphoma in adults.
Gerecitano J; Straus DJ
Expert Rev Anticancer Ther; 2006 Mar; 6(3):373-81. PubMed ID: 16503854
[TBL] [Abstract][Full Text] [Related]
10. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.
Li Y; Huang S; Wang X; Zhou D; Huang K; Guo H; Fang J; Chen C; Liu Q
J Trop Pediatr; 2010 Oct; 56(5):337-41. PubMed ID: 20065046
[TBL] [Abstract][Full Text] [Related]
11. Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab).
Jensen M; Winkler U; Manzke O; Diehl V; Engert A
Ann Hematol; 1998; 77(1-2):89-91. PubMed ID: 9760161
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment tumour lysis syndrome and acute renal failure in adult Nigerians with Burkitt's lymphoma: report of three cases and literature review.
Kagu MB; Ahmed SG; Bukar AA
Afr J Med Med Sci; 2005 Dec; 34(4):399-402. PubMed ID: 16752673
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphoma.
Pohlen M; Gerth HU; Liersch R; Koschmieder S; Mesters RM; Kessler T; Appelmann I; Müller-Tidow C; Berdel WE
Am J Hematol; 2011 Dec; 86(12):E61-4. PubMed ID: 21898532
[TBL] [Abstract][Full Text] [Related]
14. Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials.
Seidemann K; Meyer U; Jansen P; Yakisan E; Rieske K; Führer M; Kremens B; Schrappe M; Reiter A
Klin Padiatr; 1998; 210(4):279-84. PubMed ID: 9743966
[TBL] [Abstract][Full Text] [Related]
15. Delayed-onset and long-lasting severe neutropenia due to rituximab.
Hofer S; Viollier R; Ludwig C
Swiss Med Wkly; 2004 Feb; 134(5-6):79-80. PubMed ID: 15113056
[TBL] [Abstract][Full Text] [Related]
16. Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
Fayad L; Thomas D; Romaguera J
Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S57-62. PubMed ID: 18284717
[TBL] [Abstract][Full Text] [Related]
17. Tumor lysis syndrome.
Cope D
Clin J Oncol Nurs; 2004 Aug; 8(4):415-6. PubMed ID: 15354929
[No Abstract] [Full Text] [Related]
18. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
Ribrag V; Koscielny S; Bosq J; Leguay T; Casasnovas O; Fornecker LM; Recher C; Ghesquieres H; Morschhauser F; Girault S; Le Gouill S; Ojeda-Uribe M; Mariette C; Cornillon J; Cartron G; Verge V; Chassagne-Clément C; Dombret H; Coiffier B; Lamy T; Tilly H; Salles G
Lancet; 2016 Jun; 387(10036):2402-11. PubMed ID: 27080498
[TBL] [Abstract][Full Text] [Related]
19. Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20.
Abou Mourad Y; Taher A; Shamseddine A
Hematol J; 2003; 4(3):222-4. PubMed ID: 12764356
[No Abstract] [Full Text] [Related]
20. [De novo acute lymphocytic leukemia with t(14;18) complicated by tumor lysis syndrome].
Yoshida I; Takeuchi M
Nihon Naika Gakkai Zasshi; 2003 May; 92(5):865-7. PubMed ID: 12808911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
